Source ID: C24
Original URL: https://clinicaltrials.gov/study/NCT05629585
Source date (attachment preserved): 2022-11-29
Data date (attachment preserved): 2026-06-15
Checked at: 2026-10-07T18:42:25+08:00
Timezone: Asia/Taipei
Retrieval mode: stored_excerpt_review
Read level: 已存 ClinicalTrials.gov 官方公開 API 字段選錄；原始完整 HTTP JSON 未保存；本輪未網路重取
Access result: 已實讀原先保存的登錄日期、設計及必要排除字段；沒有用作者 clinical_records 結論替代
Original raw artifact SHA256: null

LOCATORS (actual reading positions):
research/clinical.json#/registry_records[source_id=C24]
本地 status.primaryCompletionDateStruct；status.lastUpdatePostDateStruct；official_title/design/primary_outcomes
Stored official API field extract: research/clinical.json#/registry_records[source_id=C24]
Official API used in original research: https://clinicaltrials.gov/api/v2/studies/NCT05629585
Original network read time: null
Original network read date (saved access_date): 2026-10-07

MINIMUM VERBATIM EXCERPT (only this block is source prose):
"primaryCompletionDateStruct": {"date": "2027-09-20", "type": "ESTIMATED"}

EXTRACTED FACTUAL FIELDS (not a reconstructed quotation):
[
  {
    "locator": "research/clinical.json#/registry_records[source_id=C24]/status.primaryCompletionDateStruct",
    "date": "2027-09-20",
    "type": "ESTIMATED",
    "meaning": "primary completion，非數據發表或監管決策日"
  },
  {
    "locator": "research/clinical.json#/registry_records[source_id=C24]/status.lastUpdatePostDateStruct",
    "date": "2026-06-15"
  },
  {
    "locator": "research/clinical.json#/registry_records[source_id=C24]/official_title, primary_outcomes[0]",
    "population": "I–III 期 TNBC，新輔助治療後有殘餘侵襲病灶",
    "primary_comparison": "Dato-DXd + durvalumab vs ICT",
    "endpoint": "iDFS"
  }
]

SCOPE / PRECISE GAP (reviewer description, not source prose):
限原保存字段和該次登錄版本；不是結果論文、不是本輪刷新登錄。

Web refs: